27% profit every 20 days?
This is what Nic Chahine averages with his option buys. Not selling covered calls or spreads… BUYING options. Most traders don’t even have a winning percentage of 27% buying options. He has an 83% win rate. Here’s how he does it.
It was reported Tuesday that activist investor Bill Ackman has accumulated a "roughly $2 billion stake" in Zoetis Inc (NYSE: ZTS).
The stock spiked on the news, soaring nearly 10 percent.
ENTER TO WIN $500 IN STOCK OR CRYPTO
Enter your email and you'll also get Benzinga's ultimate morning update AND a free $30 gift card and more!
According to the report, Ackman “could push the animal-health company to sell itself to a large drug maker like Valeant Pharmaceuticals International Inc.”
“Mr. Ackman's Pershing Square Capital Management LP has built the stake, which amounts to roughly 10 percent of Zoetis, with fellow hedge fund Sachem Head Capital Management LP,” according to sources familiar with the developments.
A Dow Jones report noted that a “spokesman for Florham Park, N.J.-based Zoetis, which has a market value of about $20 billion, said the company got a call from Mr. Ackman regarding the investment, but declined to comment on it.”
Zoetis closed at $43.72, up 8.8 percent.
27% profit every 20 days?
This is what Nic Chahine averages with his option buys. Not selling covered calls or spreads… BUYING options. Most traders don’t even have a winning percentage of 27% buying options. He has an 83% win rate. Here’s how he does it.